Nucleosides with anti-hepatitis b virus activity

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7068 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 31/522 (2006.01) A61K 31/7056 (2006.01) A61K 31/7072 (2006.01) A61P 31/20 (2006.01)

Patent

CA 2637774

A method for the treatment of a host, and in particular, a human, infected with HBV is provided that includes administering an HBV-treatment amount of a nucleoside of formula (I), (II) or (III), wherein R1 is hydrogen, fluoro, bromo, chloro, iodo, methyl or ethyl; and R2 is OH, Cl, NH2, or H; or a pharmaceutically acceptable salt of the compound, optionally in a pharmaceutically acceptable carrier or diluent.

L'invention porte sur une méthode de traitement d'un hôte, en particulier l'humain, infecté par le VHB. Le traitement comprend l'administration d'un traitement anti-VHB constitué d'une certaine quantité d'un nucléoside présentant la formule (I), (II) ou (III), où R1 est un hydrogène, un fluor, un brome, un chlore, un iode, un groupe méthyle ou éthyle; et R2 est un OH, un Cl, un NH2 ou un H; ou un sel pharmaceutiquement acceptable du composé, facultativement dans un diluant ou un vecteur pharmaceutiquement acceptable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nucleosides with anti-hepatitis b virus activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleosides with anti-hepatitis b virus activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleosides with anti-hepatitis b virus activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1432844

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.